Filippo Gustavo Dall’Olio
0000-0003-0903-6109
Publication & Citation Trends
Publications
0 total
Sarcomatoid carcinoma in Head and Neck cancers: Clinical features and prognosis
Cited by 0
Semantic Scholar
Abstract 7677: High-throughput plasma proteomics enables sarcopenia stratification and identifies the IGFBP axis as a key mediator of muscle impairment in cancer patients
Cited by 0
Semantic Scholar
Abstract 7766: Single-dose neoadjuvant atezolizumab in resectable stage IA-IIIA non-N2 NSCLC: Tumor infiltrate analysis from the PRINCEPS trial
Cited by 0
Semantic Scholar
Tumor purity as a prognostic and predictive biomarker of postoperative radiotherapy outcomes in stage IIIA-N2 non-small-cell lung cancer: a transcriptomic analysis from the Lung ART trial.
Cited by 0
Semantic Scholar
RNAseq analysis reveals the recurrent loss of heterozygosity in lung cancer and associated transcription patterns
Cited by 0
Semantic Scholar
Metabolic Tumor Volume and Immunotherapy in NSCLC-Reply.
Cited by 0
Semantic Scholar
Abstract 1097: Tumor purity (TP) as a predictive biomarker for adjuvant radiotherapy (ART) in stage IIIAN2 non-small cell lung cancer (NSCLC): An ancillary analysis of Lung ART-IFCT 0503
Cited by 0
Semantic Scholar
Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer.
Cited by 7
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(92)
Cancer Genomics and Diagnostics
(65)
Cancer Immunotherapy and Biomarkers
(51)
RNA modifications and cancer
(36)
Lung Cancer Research Studies
(31)
Affiliations
Université Paris-Sud
Centre National de la Recherche Scientifique
Université Paris-Saclay
Institut Gustave Roussy
Policlinico S.Orsola-Malpighi